Chennai Meenakshi Multispeciality Hospital Ltd

Ticker: CMMHOSP
Decent 66/100

☆ Add to Watchlist

Investing Reference

Price
52.34
Market Cap
39.09
Debt/Equity
ROE %
PB
-20.6838
Promoter %
57.098
Pledge %
0.000
1Y Rev Growth %
-7.758
5Y Rev Growth %
6.131
NP Margin %
-3.869
NP Margin 5Y Avg %
0.715

Trading Reference

1M Return %
14.679
6M Return %
64.075
1Y Return %
38.173
% Away 52W High
14.444
% Away 52W Low
84.686
Daily Volume
3827
Investment Verdict
Hold
Score 74/100 · Position size: 30%
Fundamentals are OK but not compelling. Maintain current position; avoid fresh adds.
Trading Verdict
Watch
Score 64/100 · Position size: 10%
Momentum weak or trend adverse. Avoid trading at this point.
Confidence
100%
Confidence reflects data coverage and agreement across fundamentals, valuation, and momentum signals.

Summary

Chennai Meenakshi Multispeciality Hospital Ltd shows strong growth potential in the healthcare sector.

✅ Positives
  • Consistent revenue growth over the past years
  • Strong patient base and community trust
  • Diverse range of medical services offered

⚠️ Negatives
  • High competition in the healthcare market
  • Regulatory challenges affecting operations
  • Dependence on local economic conditions

Verdict
Moderate growth potential with some risks.
Recommendation: Consider a buy for long-term investors.
Upside Probability: 25%   |   Downside Probability: 15%
Last generated: 30/10/2025

More Options

Business Overview

Chennai Meenakshi Multispeciality Hospital Ltd is a leading healthcare provider dedicated to delivering high-quality medical services across various specialties. Catering to patients of all ages, the hospital combines advanced technology with compassionate care to ensure optimal health outcomes. Its commitment to excellence and patient-centric approach makes it a trusted choice for individuals seeking reliable medical attention. With a team of experienced professionals, it stands out in the healthcare landscape, emphasizing innovation and comprehensive care.

  • Established leader in multispeciality healthcare
  • State-of-the-art medical technology
  • Experienced and dedicated healthcare professionals
  • Patient-centric approach to treatment
  • Wide range of specialties under one roof

Investment Thesis

Chennai Meenakshi Multispeciality Hospital Ltd is poised for growth with a strong promoter group, enhancing its credibility in the healthcare sector. The company's focus on digital services presents a significant growth runway, while its attractive valuation compared to peers makes it an appealing investment opportunity for retail investors.

  • Strong promoter group with a proven track record in healthcare.
  • Robust growth potential in digital healthcare services.
  • Attractive valuation compared to industry peers, enhancing investment appeal.
  • Consistent financial performance with a focus on quality care.
  • Strategic initiatives to expand service offerings and market reach.

Opportunity vs Risk

Opportunities
  • Growing healthcare demand in India
  • Expansion plans in new regions
  • Strong brand reputation
  • Government healthcare initiatives
  • Rising medical tourism potential
Risks ⚠️
  • Regulatory changes affecting operations
  • High competition in healthcare sector
  • Economic downturn impact on patients
  • Dependence on skilled workforce
  • Potential for rising operational costs

Peer Perspective

Chennai Meenakshi Multispeciality Hospital Ltd trades at a discount to peers like Apollo Hospitals and Fortis Healthcare, necessitating consistent margin stability and growth acceleration for potential rerating in the competitive healthcare sector.

Future Outlook

Chennai Meenakshi Multispeciality Hospital Ltd is well-positioned for growth, provided it maintains effective execution and cost control strategies. Continued focus on quality care and expansion could enhance its market presence and profitability.

AI FAQs for Retail Users

  • Q: What services does Chennai Meenakshi Multispeciality Hospital offer?
    A: The hospital provides a range of medical services including surgeries, diagnostics, and patient care across various specialties.
  • Q: Is Chennai Meenakshi Multispeciality Hospital publicly traded?
    A: Yes, it is listed on Indian stock exchanges, allowing investors to buy and sell shares.
  • Q: What factors can affect the stock price of Chennai Meenakshi Multispeciality Hospital?
    A: Stock prices can be influenced by financial performance, healthcare regulations, and market conditions.
  • Q: How can I invest in Chennai Meenakshi Multispeciality Hospital shares?
    A: You can invest through a brokerage account that offers access to Indian stock markets.
  • Q: What should I consider before investing in this stock?
    A: Consider the hospital's financial health, industry trends, and your own investment goals.
📊 Stock Investment Checklist (100 Points)
Chennai Meenakshi Multispeciality Hospital Ltd • Updated: 2025-09-16 20:11:53
  • 10
    Business
    High
    The healthcare sector is growing, but competition is intense.
  • 10
    Growth
    High
    Revenue growth has been consistent, but profit margins are under pressure.
  • 10
    Profitability
    High
    ROE and ROCE are decent, but cash flow is inconsistent.
  • 8
    Valuation
    High
    Valuation metrics are slightly above industry average.
  • 7
    Balance
    High
    Debt levels are manageable, but liquidity is a concern.
  • 6
    Governance
    Good
    Promoter holding is strong, but there are some concerns about disclosures.
  • 5
    Drivers
    Good
    Growth drivers exist, but execution risks are significant.
  • 5
    Technicals
    Good
    Market sentiment is neutral with low liquidity.
Final Score & Verdict
Score 66 / 100 • Decent
Chennai Meenakshi Multispeciality Hospital Ltd shows potential for growth but faces challenges in profitability and execution risks. It is advisable to monitor closely before making investment decisions.

AI Confidence Score

Instead of just “overall score,” broken into categories:

  • Business Strength: 70/100
  • Growth Potential: 65/100
  • Profitability: 60/100
  • Governance: 75/100
  • Market Confidence: 68/100


More Like This

Latest News

More ↗

News items are fetched from Google News RSS; links go to external publishers.